ProQR Therapeutics N.V. Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PRQR Company Description
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
PRQR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PRQR Smart Score
Score Breakdown
PRQR Company Description
Show More
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PRQR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRQR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on PRQR's company Twitter account
WallStreetBets
Number of mentions of PRQR in WallStreetBets Daily Discussion
PRQR News
Recent insights relating to PRQR
CNBC Recommendations
Recent picks made for PRQR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PRQR
Corporate Flights
Flights by private jets registered to PRQR
Our Analysis